众所周知抗肿瘤药物在杀伤肿瘤细胞的同时,也会导致对人体正常组织、器官的损伤,特别是对心脏的毒性反应,导致心肌缺血、心律失常,严重的心脏毒性反应可能直接影响肿瘤患者的后续治疗,因此,保护肿瘤患者的心脏已成为大家共同关注的话题。 It is well-known that anti-tumor drugs kill tumor cells while also causing damage to normal human tissues and organs, especially toxicity to the heart, resulting in myocardial ischemia and arrhythmia. Severe cardiotoxicity may directly affect cancer patients. Follow-up treatment, therefore, to protect the heart of patients with cancer has become a topic of common concern.